TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21999723

Group type: EXPERIMENTAL
Intervention: Non-caloric carbonated beverage (B+CO2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-caloric beverage without CO2 (B‐CO2)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study: 18454662

Group type: EXPERIMENTAL
Intervention: Minocycline microspheres (1 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Chlorhexidine gel
Number of subjects: 32
Study: 16567269

Group type: EXPERIMENTAL
Intervention: Individualized menu suggestions and education on food exchanges
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional patient education method
Number of subjects: 70
Study: 14513159

Group type: EXPERIMENTAL
Intervention: Complete AED withdrawal (Group 1)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Partial AED withdrawal (Group 2)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 94
Study: 10737284

Group type: EXPERIMENTAL
Intervention: MUFA diet (extra-virgin olive oil)
Number of subjects: 23

Group type: COMPARATOR
Intervention: PUFA diet (sunflower oil)
Number of subjects: 23
Study: 9366815

Group type: EXPERIMENTAL
Intervention: UltraPulse laser system
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SilkTouch laser system
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 28
Study: 1543376

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (Desmospray) for one month
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (Desmospray) for three months
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Desmopressin responsive enuretics
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Desmopressin non-responders
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-enuretic control children
Number of subjects: 55
Study: 3633416

Group type: EXPERIMENTAL
Intervention: Transparent dressings (Tegaderm® transparent dressing, 3M, St. Paul, MN) changed once a week (n = 188)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Paper tape dressings changed three times a week (n = 177)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Transparent dressings
Number of subjects: 365

Group type: COMPARATOR
Intervention: Paper tape dressings
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Transparent dressings worn up to 7 days
Number of subjects: 365
Study: 29428326

Group type: EXPERIMENTAL
Intervention: Modified definition for OSA (AHI 5-14.9 per hour with oxygen desaturation)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Classic definition for OSA (AHI ≥15)
Number of subjects: 106
Study: 26795673

Group type: EXPERIMENTAL
Intervention: Facility-based aerobic exercise utilizing a portable stationary pedal exerciser
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 24867512

Group type: EXPERIMENTAL
Intervention: Colinox® (combination of Simethicone and Bacillus coagulans)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 22322738

Group type: EXPERIMENTAL
Intervention: Not applicable (observational study)
Number of subjects: 1335
Study: 20647174

Group type: EXPERIMENTAL
Intervention: Elimination diet based on IgG antibodies
Number of subjects: 30
Study: 17875547

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) standard dose (10 mg/m2/week)
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) higher dose (15 mg/m2/week or 30 mg/m2/week)
Number of subjects: 521

Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Baseline disability
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Other determinants
Number of subjects: 521
Study: 19266263

Group type: EXPERIMENTAL
Intervention: Standardized superficial thermal injury (49 degrees C for 5 min)
Number of subjects: 14
Study: 15878921

Group type: EXPERIMENTAL
Intervention: Gene expression profiles during the early luteal phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gene expression profiles during the mid-luteal phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microarray data validation
Number of subjects: 0
Study: 11745596

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Breathing exercises
Number of subjects: 42
Study: 9926051

Group type: EXPERIMENTAL
Intervention: Community mental health service intervention
Number of subjects: 514

Group type: COMPARATOR
Intervention: Case identification and patient interviews
Number of subjects: 514
Study: 8056795

Group type: EXPERIMENTAL
Intervention: Dynamic external fixation (Clyburn device)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Static external fixation (AO/ASIF device)
Number of subjects: 50
Study: 3260082

Group type: EXPERIMENTAL
Intervention: Isoflurane 1.15 vol.%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enflurane 1.68 vol.%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isoflurane (during norepinephrine-induced hypertension)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enflurane (during norepinephrine-induced hypertension)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isoflurane (during controlled hyperventilation)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enflurane (during controlled hyperventilation)
Number of subjects: 20
Study: 30169740

Group type: EXPERIMENTAL
Intervention: COach2Quit (n = 50)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Brief advice + COach2Quit (n = 50)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Brief advice only (n = 52)
Number of subjects: 102
Study: 30542300

Group type: EXPERIMENTAL
Intervention: Metformin (1,000 mg day(-1))
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Betahistine (36 mg day(-1))
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Betahistine
Number of subjects: 67
Study: 26742063

Group type: EXPERIMENTAL
Intervention: Extra Fit! (EF!) education program for two successive school years (mean 7.6 h during 16 weeks per school per year)
Number of subjects: 1112

Group type: COMPARATOR
Intervention: Control group (usual curriculum)
Number of subjects: 1112
Study: 24500112

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (20 g L(‐1))
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mineral water (Control)
Number of subjects: 10
Study: 22707261

Group type: EXPERIMENTAL
Intervention: High monounsaturated fatty acids (HMUFA) diet
Number of subjects: 75
Study: 19284927

Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg (for subjects aged >or=65 years)
Number of subjects: 1213

Group type: EXPERIMENTAL
Intervention: Ramelteon 16 mg (for subjects aged 18 to 64 years)
Number of subjects: 1213

Group type: COMPARATOR
Intervention: Placebo (during 3-day run out)
Number of subjects: 1213
Study: 17975239

Group type: EXPERIMENTAL
Intervention: Posterior approach to the lumbar plexus
Number of subjects: 46

Group type: COMPARATOR
Intervention: Fascia iliaca compartment block
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Classic transgluteal approach for sciatic nerve blockade
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Subgluteal approach for sciatic nerve blockade
Number of subjects: 46

Group type: COMPARATOR
Intervention: Electrostimulation of the tibial nerve
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Multiple-injection technique for sciatic and femoral blocks
Number of subjects: 46
Study: 16161895

Group type: EXPERIMENTAL
Intervention: Encouragement during visual acuity testing
Number of subjects: 50

Group type: COMPARATOR
Intervention: No encouragement during visual acuity testing
Number of subjects: 50
Study: 11968894

Group type: EXPERIMENTAL
Intervention: Noncontact radiant warming device with offloading therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Offloading therapy only
Number of subjects: 36
Study: 10435378

Group type: EXPERIMENTAL
Intervention: MPS (Myocardial Perfusion Scanning)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: RNV (Radionuclide Ventriculography)
Number of subjects: 21
Study: 7480556

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2300087

Group type: EXPERIMENTAL
Intervention: Levamisole plus fluorouracil
Number of subjects: 1296

Group type: EXPERIMENTAL
Intervention: Levamisole alone
Number of subjects: 1296

Group type: COMPARATOR
Intervention: Control (observation)
Number of subjects: 1296

Group type: EXPERIMENTAL
Intervention: Fluorouracil alone
Number of subjects: 1296
Study: 368820

Group type: EXPERIMENTAL
Intervention: FK 33-824
Number of subjects: 26
Study: 31622290

Group type: EXPERIMENTAL
Intervention: Kaltenborn mobilization with thermotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Kaltenborn mobilization alone
Number of subjects: 30
Study: 26667107

Group type: EXPERIMENTAL
Intervention: Transforming Your Life program
Number of subjects: 98

Group type: COMPARATOR
Intervention: Diabetes Prevention Program
Number of subjects: 98
Study: 25640027

Group type: EXPERIMENTAL
Intervention: Flexible Ureteroscopy (fURS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Extracorporeal Shock Wave Lithotripsy (ESWL)
Number of subjects: 30
Study: 23499568

Group type: EXPERIMENTAL
Intervention: Peak Universal Adhesive System, self-etch (PkSe)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Peak Universal Adhesive System, etch-and-rinse (PkEr)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All Bond Universal, self-etch (AlSe)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal Adhesive, self-etch (ScSe)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal Adhesive, etch-and-rinse (ScEr)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All Bond Universal, etch-and-rinse (AlEr)
Number of subjects: 40
Study: 21378594

Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine
Number of subjects: 6568

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6568
Study: 19033449

Group type: EXPERIMENTAL
Intervention: Lercanidipine (LER) 20 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fluvastatin (FV) 40 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lercanidipine (LER) 20 mg + Fluvastatin (FV) 40 mg
Number of subjects: 8
Study: 17577037

Group type: EXPERIMENTAL
Intervention: HD-FU (3,000 mg/m2/24 hours)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: HD-FU/FA (2,600 mg/m2/24 hours plus dl-FA 500 mg/m2 or l-FA 250 mg/m2)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: HD-FU/FA/Cis (2,000 mg/m2/24 hours plus FA plus biweekly Cis 50 mg/m2)
Number of subjects: 145
Study: 15539726

Group type: EXPERIMENTAL
Intervention: Room air (Fio(2) 0.21)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Supplemental oxygen (Fio(2) > 0.21)
Number of subjects: 288
Study: 11773932

Group type: EXPERIMENTAL
Intervention: Ionic low‐molecular‐weight medium ioxaglate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ionic high‐molecular‐weight medium diatrizoate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonionic medium iohexol
Number of subjects: 30
Study: 9599891

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with adrenaline 1:200,000
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 48
Study: 8020527

Group type: EXPERIMENTAL
Intervention: Iomeprol contrast medium at concentrations of 150, 200, 250, 300, 350, and 400 mgI/ml
Number of subjects: 4811

Group type: EXPERIMENTAL
Intervention: Iomeprol contrast medium
Number of subjects: 4811
Study: 2499037

Group type: EXPERIMENTAL
Intervention: Interferon alpha-2b, Introna, 3 MU 3 times weekly subcutaneously
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 1130437

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Antihypertensive medications (both groups)
Number of subjects: 100
Study: 30240936

Group type: EXPERIMENTAL
Intervention: Reduced BW (80%BW)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Normal BW (100%BW)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Increased BW (120%BW)
Number of subjects: 24
Study: 28829160

Group type: EXPERIMENTAL
Intervention: Arterialized-venous reference samples
Number of subjects: 21

Group type: COMPARATOR
Intervention: Venous reference samples
Number of subjects: 21

Group type: COMPARATOR
Intervention: Capillary reference samples
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Arterialized-venous glucose
Number of subjects: 21

Group type: COMPARATOR
Intervention: Venous glucose
Number of subjects: 21

Group type: COMPARATOR
Intervention: Capillary glucose
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Arterialization effectiveness
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Inconvenience related to arterialization
Number of subjects: 21
Study: 25547033

Group type: EXPERIMENTAL
Intervention: Two-signal montage
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: One-signal montage
Number of subjects: 15

Group type: COMPARATOR
Intervention: Reference montage
Number of subjects: 15
Study: 23277305

Group type: EXPERIMENTAL
Intervention: ticagrelor
Number of subjects: 18624

Group type: COMPARATOR
Intervention: clopidogrel
Number of subjects: 18624
Study: 20405236

Group type: EXPERIMENTAL
Intervention: A-line ARX index (AAI) monitoring
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard clinical parameters (SCP) monitoring
Number of subjects: 60
Study: 20146881

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (n-3 PUFA) 2 g/day for 3 months
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 17156509

Group type: EXPERIMENTAL
Intervention: Propofol (intravenous anaesthetic)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Desflurane (volatile anaesthetic)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Volatile anaesthetics
Number of subjects: 150
Study: 15490867

Group type: EXPERIMENTAL
Intervention: Dining with a caregiver
Number of subjects: 200

Group type: COMPARATOR
Intervention: Dining alone
Number of subjects: 200
Study: 11212626

Group type: EXPERIMENTAL
Intervention: Associative priming
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive viewing of primes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active processing of primes
Number of subjects: 0
Study: 10349437

Group type: EXPERIMENTAL
Intervention: Inactivated and trivalent vaccine containing strains of Leptospira canicola, icterohaemorrhagiae and pomona
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 8610220

Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intravenous lidocaine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intravenous ketamine
Number of subjects: 31
Study: 2752395

Group type: EXPERIMENTAL
Intervention: Diphenylhydantoin (2‐3 mg/kg/day for 6 months)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 17
Study: 177474

Group type: EXPERIMENTAL
Intervention: daily prednisone therapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: daily methylprednisolone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: alternate-day methylprednisolone
Number of subjects: 20

Group type: COMPARATOR
Intervention: alternate-day therapy
Number of subjects: 20
Study: 31646668

Group type: EXPERIMENTAL
Intervention: 7-day ibuprofen group (600 mg three times a day, N=29)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 3-day ibuprofen group (N=30)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo group (N=30)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Histomorphometric outcomes (all groups)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Bone biomarkers (Osteocalcin and CrossLaps measured at multiple time points)
Number of subjects: 95
Study: 31056404

Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block
Number of subjects: 123

Group type: COMPARATOR
Intervention: Single-shot adductor canal block
Number of subjects: 123
Study: 28844816

Group type: EXPERIMENTAL
Intervention: Guadecitabine 60 mg/m2 on a 5-day schedule
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Guadecitabine 90 mg/m2 on a 5-day schedule
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Guadecitabine 60 mg/m2 on a 10-day schedule
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Guadecitabine (all doses and schedules)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Adverse events for 5-day schedule
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Adverse events for 10-day schedule
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Serious adverse events for 5-day schedule
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Serious adverse events for 10-day schedule
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Adverse events leading to death
Number of subjects: 107
Study: 23807352

Group type: EXPERIMENTAL
Intervention: Ex‐PRESS
Number of subjects: 64

Group type: COMPARATOR
Intervention: trabeculectomy
Number of subjects: 64
Study: 24260516

Group type: EXPERIMENTAL
Intervention: 40 mL of contrast medium (Group I)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 50 mL of contrast medium (Group II)
Number of subjects: 54
Study: 20584756

Group type: EXPERIMENTAL
Intervention: Oral fluid and Trendelenburg position (OT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intravenous fluid (IV)
Number of subjects: 28
Study: 19852841

Group type: EXPERIMENTAL
Intervention: Acupuncture plus usual care
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 16769272

Group type: EXPERIMENTAL
Intervention: Advancement Flap (AF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fistulotomy with Sphincter Reconstruction (FSR)
Number of subjects: 60
Study: 15622128

Group type: EXPERIMENTAL
Intervention: Vagal nerve stimulation (VNS) in rapid cycle mode
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Vagal nerve stimulation (VNS) in normal mode
Number of subjects: 11

Group type: COMPARATOR
Intervention: Vagal nerve stimulation (VNS) switched off
Number of subjects: 11
Study: 15314548

Group type: EXPERIMENTAL
Intervention: 5'‐DFUR (Furtulon) 800 mg/d for 2 years
Number of subjects: 287

Group type: COMPARATOR
Intervention: OK‐432 plus 5'‐DFUR by the same regimen as in group A
Number of subjects: 287
Study: 10838236

Group type: EXPERIMENTAL
Intervention: Tidal volume of 500 ml
Number of subjects: 17

Group type: COMPARATOR
Intervention: Tidal volume of 1000 ml
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both tidal volumes
Number of subjects: 17
Study: 9182472

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 45
Study: 8468435

Group type: EXPERIMENTAL
Intervention: Moclobemide (150-525 mg/day, mean 307 mg during last week)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Imipramine (50-175 mg/day, mean 100 mg during last week)
Number of subjects: 127
Study: 3702577

Group type: EXPERIMENTAL
Intervention: Dapsone 1 mg/kg body weight/day
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dapsone 4 mg/kg body weight/day
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Dapsone treatment (both dosages)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (Q group with macular lesions)
Number of subjects: 26
Study: 3076782

Group type: EXPERIMENTAL
Intervention: bezafibrate (600 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 30657017

Group type: EXPERIMENTAL
Intervention: Portable fibrobronchoscopy treatment
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (routine sputum suction, anti-infection drugs, sputum-reducing drugs)
Number of subjects: 86
Study: 28523393

Group type: EXPERIMENTAL
Intervention: Flavored anesthetic masks smeared with a flavor of child's choice
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-flavored anesthetic masks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flavored anesthetic masks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Commercially available pre-scented masks
Number of subjects: 60
Study: 25046032

Group type: EXPERIMENTAL
Intervention: Pelvic plexus block (PPB) with 2.5 mL 2% lignocaine injection bilaterally along with intrarectal local anaesthesia (IRLA) with 10 mL 2% lignocaine jelly
Number of subjects: 139

Group type: COMPARATOR
Intervention: Periprostatic nerve block (PNB) along with intrarectal local anaesthesia (IRLA) with 10 mL 2% lignocaine jelly
Number of subjects: 139

Group type: COMPARATOR
Intervention: Intrarectal local anaesthesia (IRLA) without any type of nerve block
Number of subjects: 139
Study: 23739984

Group type: EXPERIMENTAL
Intervention: Higher voltage coag mode (30 W)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lower voltage blend mode (30 W)
Number of subjects: 40
Study: 21109578

Group type: EXPERIMENTAL
Intervention: Semantic decisions on written words
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Semantic decisions on pictures of objects
Number of subjects: 60
Study: 19404053

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted anterior resection
Number of subjects: 153

Group type: COMPARATOR
Intervention: Open anterior resection
Number of subjects: 153
Study: 17658017

Group type: EXPERIMENTAL
Intervention: ON-Q bupivicaine pain pump
Number of subjects: 40

Group type: COMPARATOR
Intervention: meperidine PCA
Number of subjects: 40
Study: 14992883

Group type: COMPARATOR
Intervention: Atenolol (50 mg/daily)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Sotalol (80 mg twice daily)
Number of subjects: 253
Study: 11843924

Group type: EXPERIMENTAL
Intervention: Antiseptic cream applied to the nose twice daily for 4 weeks
Number of subjects: 103

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 103
Study: 10546408

Group type: EXPERIMENTAL
Intervention: Rifaximin (5 ml, equal to 100 mg, x 4/day for 3 days on average)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Neomycin + bacitracin (5 ml x 4/day for 4 days on average)
Number of subjects: 31
Study: 8044619

Group type: EXPERIMENTAL
Intervention: Bowel preparation (n = 89)
Number of subjects: 169

Group type: COMPARATOR
Intervention: No bowel preparation (n = 97)
Number of subjects: 169